These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10914493)

  • 21. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.
    Thilenius AR; Braun K; Russell JH
    Eur J Immunol; 1997 May; 27(5):1108-14. PubMed ID: 9174599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I; Tillman DM; Harwood FG; Mihalik R; Houghton JA
    Cancer Res; 2000 May; 60(10):2643-50. PubMed ID: 10825136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas and other cell death signaling pathways.
    Depraetere V; Golstein P
    Semin Immunol; 1997 Apr; 9(2):93-107. PubMed ID: 9194220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
    Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
    J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
    Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
    Frost P; Caliliw R; Belldegrun A; Bonavida B
    Int J Oncol; 2003 Feb; 22(2):431-7. PubMed ID: 12527945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA; Cowan RG; Harman RM; Quirk SM
    Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-gamma.
    Létuvé S; Druilhe A; Grandsaigne M; Aubier M; Pretolani M
    J Leukoc Biol; 2001 Nov; 70(5):767-75. PubMed ID: 11698497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
    VanOosten RL; Griffith TS
    Cancer Res; 2007 Dec; 67(24):11980-90. PubMed ID: 18089829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    Stalder T; Hahn S; Erb P
    J Immunol; 1994 Feb; 152(3):1127-33. PubMed ID: 7507960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
    Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
    Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors.
    Wang R; Rogers AM; Ratliff TL; Russell JH
    J Immunol; 1996 Oct; 157(7):2961-8. PubMed ID: 8816403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated B cells express functional Fas ligand.
    Hahne M; Renno T; Schroeter M; Irmler M; French L; Bornard T; MacDonald HR; Tschopp J
    Eur J Immunol; 1996 Mar; 26(3):721-4. PubMed ID: 8605944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fas involvement in cytotoxicity mediated by human NK cells.
    Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z
    Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis.
    Thilenius AR; Sabelko-Downes KA; Russell JH
    J Immunol; 1999 Jan; 162(2):643-50. PubMed ID: 9916681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of two distinct killing mechanisms in bystander target cell lysis induced by a cytotoxic T lymphocyte clone.
    Kuwano K; Arai S
    Cell Immunol; 1996 May; 169(2):288-93. PubMed ID: 8620557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.